Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Mindy3 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Mindy3 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MINDY3 mRNA | CTD | PMID:22206623 | Mindy3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Mindy3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of MINDY3 mRNA | CTD | PMID:22206623 | Mindy3 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of MINDY3 mRNA | CTD | PMID:25380136 | Mindy3 | Rat | 17beta-estradiol | increases expression | ISO | Mindy3 (Mus musculus) | 6480464 | Estradiol results in increased expression of MINDY3 mRNA | CTD | PMID:39298647 | Mindy3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MINDY3 mRNA | CTD | PMID:21215274 | Mindy3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Mindy3 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of MINDY3 mRNA | CTD | PMID:16214954 | Mindy3 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of MINDY3 mRNA | CTD | PMID:30851411 | Mindy3 | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Mindy3 | Rat | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of MINDY3 mRNA | CTD | PMID:25380136 | Mindy3 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Mindy3 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Mindy3 (Mus musculus) | 6480464 | bisphenol S results in increased expression of MINDY3 mRNA | CTD | PMID:39298647 | Mindy3 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of MINDY3 mRNA | CTD | PMID:30047161 | Mindy3 | Rat | aflatoxin B1 | increases methylation | ISO | MINDY3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MINDY3 gene; Aflatoxin B1 results in increased methylation more ... | CTD | PMID:28458013|PMID:30157460 | Mindy3 | Rat | aflatoxin B1 | decreases methylation | ISO | MINDY3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of MINDY3 gene | CTD | PMID:27153756 | Mindy3 | Rat | all-trans-retinoic acid | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of MINDY3 mRNA | CTD | PMID:33167477 | Mindy3 | Rat | arsane | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MINDY3 more ... | CTD | PMID:39836092 | Mindy3 | Rat | arsenic atom | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MINDY3 more ... | CTD | PMID:39836092 | Mindy3 | Rat | arsenite(3-) | increases methylation | ISO | MINDY3 (Homo sapiens) | 6480464 | arsenite results in increased methylation of MINDY3 promoter | CTD | PMID:23974009 | Mindy3 | Rat | atrazine | decreases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of MINDY3 mRNA | CTD | PMID:22378314 | Mindy3 | Rat | benzo[a]pyrene | affects methylation | ISO | MINDY3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MINDY3 promoter | CTD | PMID:27901495 | Mindy3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MINDY3 mRNA | CTD | PMID:25181051 | Mindy3 | Rat | bisphenol A | decreases methylation | ISO | MINDY3 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MINDY3 gene | CTD | PMID:31601247 | Mindy3 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MINDY3 gene | CTD | PMID:28505145 | Mindy3 | Rat | Butylbenzyl phthalate | decreases methylation | ISO | Mindy3 (Mus musculus) | 6480464 | butylbenzyl phthalate results in decreased methylation of MINDY3 intron | CTD | PMID:28392331 | Mindy3 | Rat | cadmium atom | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MINDY3 more ... | CTD | PMID:35301059 | Mindy3 | Rat | cadmium atom | multiple interactions | ISO | Mindy3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MINDY3 more ... | CTD | PMID:37236586 | Mindy3 | Rat | cadmium dichloride | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of MINDY3 mRNA | CTD | PMID:38568856 | Mindy3 | Rat | cadmium dichloride | multiple interactions | ISO | Mindy3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MINDY3 more ... | CTD | PMID:37236586 | Mindy3 | Rat | cadmium dichloride | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MINDY3 more ... | CTD | PMID:35301059 | Mindy3 | Rat | carbon nanotube | increases expression | ISO | Mindy3 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of MINDY3 mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Mindy3 | Rat | cisplatin | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of MINDY3 mRNA | CTD | PMID:27392435 | Mindy3 | Rat | crocidolite asbestos | decreases expression | ISO | Mindy3 (Mus musculus) | 6480464 | Asbestos, Crocidolite results in decreased expression of MINDY3 mRNA | CTD | PMID:29279043 | Mindy3 | Rat | cyclosporin A | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MINDY3 mRNA | CTD | PMID:20106945|PMID:25562108 | Mindy3 | Rat | dexamethasone | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Mindy3 | Rat | Dibutyl phosphate | affects expression | ISO | MINDY3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of MINDY3 mRNA | CTD | PMID:37042841 | Mindy3 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of MINDY3 mRNA | CTD | PMID:21266533 | Mindy3 | Rat | dorsomorphin | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Mindy3 | Rat | epoxiconazole | decreases expression | ISO | Mindy3 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of MINDY3 mRNA | CTD | PMID:35436446 | Mindy3 | Rat | ethyl methanesulfonate | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of MINDY3 mRNA | CTD | PMID:23649840 | Mindy3 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of MINDY3 mRNA | CTD | PMID:24136188 | Mindy3 | Rat | folic acid | multiple interactions | ISO | Mindy3 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MINDY3 mRNA | CTD | PMID:22206623 | Mindy3 | Rat | formaldehyde | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of MINDY3 mRNA | CTD | PMID:23649840 | Mindy3 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MINDY3 mRNA | CTD | PMID:22061828|PMID:33387578 | Mindy3 | Rat | indometacin | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] more ... | CTD | PMID:28628672 | Mindy3 | Rat | ivermectin | decreases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of MINDY3 protein | CTD | PMID:32959892 | Mindy3 | Rat | lead(0) | affects methylation | ISO | MINDY3 (Homo sapiens) | 6480464 | Lead affects the methylation of MINDY3 gene | CTD | PMID:31636367 | Mindy3 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of MINDY3 mRNA | CTD | PMID:30047161 | Mindy3 | Rat | methyl methanesulfonate | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of MINDY3 mRNA | CTD | PMID:23649840 | Mindy3 | Rat | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of MINDY3 mRNA | CTD | PMID:25380136 | Mindy3 | Rat | nefazodone | decreases expression | EXP | | 6480464 | nefazodone results in decreased expression of MINDY3 mRNA | CTD | PMID:24136188 | Mindy3 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MINDY3 mRNA | CTD | PMID:33387578 | Mindy3 | Rat | rac-lactic acid | decreases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of MINDY3 mRNA | CTD | PMID:30851411 | Mindy3 | Rat | SB 431542 | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Mindy3 | Rat | sodium arsenite | affects expression | ISO | MINDY3 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of MINDY3 mRNA | CTD | PMID:29319823 | Mindy3 | Rat | sodium arsenite | decreases expression | ISO | Mindy3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of MINDY3 mRNA | CTD | PMID:37682722 | Mindy3 | Rat | sodium arsenite | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of MINDY3 more ... | CTD | PMID:39836092 | Mindy3 | Rat | sodium arsenite | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MINDY3 mRNA | CTD | PMID:38568856 | Mindy3 | Rat | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of MINDY3 mRNA | CTD | PMID:19281266 | Mindy3 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of MINDY3 mRNA | CTD | PMID:30047161 | Mindy3 | Rat | sunitinib | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of MINDY3 mRNA | CTD | PMID:31533062 | Mindy3 | Rat | temozolomide | decreases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of MINDY3 mRNA | CTD | PMID:31758290 | Mindy3 | Rat | testosterone | decreases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of MINDY3 mRNA | CTD | PMID:33359661 | Mindy3 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of MINDY3 mRNA | CTD | PMID:34492290 | Mindy3 | Rat | titanium dioxide | decreases methylation | ISO | Mindy3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MINDY3 gene | CTD | PMID:35295148 | Mindy3 | Rat | triptonide | increases expression | ISO | Mindy3 (Mus musculus) | 6480464 | triptonide results in increased expression of MINDY3 mRNA | CTD | PMID:33045310 | Mindy3 | Rat | troglitazone | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | troglitazone results in increased expression of MINDY3 mRNA | CTD | PMID:19140230 | Mindy3 | Rat | tungsten | increases expression | ISO | Mindy3 (Mus musculus) | 6480464 | Tungsten results in increased expression of MINDY3 mRNA | CTD | PMID:30912803 | Mindy3 | Rat | valproic acid | affects expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MINDY3 mRNA | CTD | PMID:25979313 | Mindy3 | Rat | valproic acid | increases expression | ISO | MINDY3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MINDY3 mRNA | CTD | PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799 | Mindy3 | Rat | valproic acid | multiple interactions | ISO | MINDY3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















